StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
410
This month
4
This week
1
This year
22
Publishing Date
2023 - 12 - 15
3
2023 - 10 - 26
4
2023 - 08 - 01
3
2023 - 04 - 18
4
2023 - 01 - 18
3
2022 - 12 - 19
3
2022 - 10 - 10
2
2022 - 09 - 19
2
2022 - 09 - 07
2
2022 - 08 - 11
2
2022 - 08 - 04
2
2022 - 07 - 19
2
2022 - 06 - 14
2
2022 - 06 - 06
4
2022 - 05 - 11
4
2022 - 05 - 04
2
2022 - 04 - 25
3
2022 - 04 - 12
2
2022 - 04 - 11
4
2022 - 03 - 08
3
2022 - 03 - 01
3
2022 - 02 - 23
2
2022 - 02 - 22
2
2022 - 02 - 11
2
2022 - 01 - 24
2
2021 - 12 - 13
2
2021 - 12 - 03
3
2021 - 11 - 11
2
2021 - 11 - 04
3
2021 - 11 - 02
3
2021 - 10 - 18
2
2021 - 10 - 13
3
2021 - 09 - 30
2
2021 - 09 - 28
4
2021 - 09 - 21
3
2021 - 09 - 18
2
2021 - 09 - 16
2
2021 - 08 - 16
3
2021 - 08 - 05
2
2021 - 07 - 09
2
2021 - 06 - 29
2
2021 - 06 - 28
2
2021 - 06 - 24
2
2021 - 06 - 22
4
2021 - 06 - 21
2
2021 - 06 - 17
2
2021 - 06 - 11
2
2021 - 06 - 01
3
2021 - 05 - 27
2
2021 - 05 - 21
2
2021 - 05 - 06
2
2021 - 04 - 16
2
2021 - 04 - 12
2
2021 - 04 - 08
2
2021 - 04 - 07
3
2021 - 04 - 06
2
2021 - 03 - 10
3
2021 - 02 - 10
3
2021 - 01 - 28
2
2021 - 01 - 21
2
Sector
Commercial services
3
Consumer non-durables
3
Distribution services
1
Electronic technology
3
Finance
3
Health services
4
Health technology
410
Manufacturing
6
N/a
1
Process industries
1
Producer manufacturing
1
Professional, scientific, and technical services
4
Technology services
2
Tags
Agreement
14
Alliances
26
Alzheimer’s
8
Announcement
14
Antibody
20
Application
17
Approval
19
Authorization
11
Authorized
11
Biomidwest
9
Biotech-bay
10
Cancer
44
China
26
Clinical-trials-phase-ii
9
Clinical-trials-phase-iii
10
Collaboration
27
Conference
14
Covid
37
Covid-19
27
Dermatitis
8
Designation
20
Diabetes
12
Diagnostic
9
Disease
27
Drug
40
Earnings
10
Ema
10
Emergency use authorization
15
Fda
58
Fda-approvals
8
Financial
14
Financial results
10
Global
14
Granted
9
Growth
14
Heart
10
Injection
11
License
14
Market
28
Meeting
12
Merge
14
N/a
242
New drug
9
Pharma
8
Phase 1
8
Phase 2
11
Phase 3
20
Positive
16
Report
15
Research
39
Results
44
Review
11
Risk
15
Sabizabulin
18
Study
18
Therapeutics
28
Therapy
39
Treatment
110
Trial
43
Update
10
Entities
Abbott laboratories
5
Abbvie inc.
9
Abcellera biologics inc
7
Ac immune sa
5
Aclaris therapeutics, inc.
1
Acrivon therapeutics, inc.
1
Acumen pharmaceuticals inc
1
Adagio therapeutics inc
1
Adaptimmune therapeutics plc
1
Addex therapeutics ltd
1
Agilent technologies, inc.
2
Akouos, inc.
2
Akoya biosciences inc
1
Albemarle corporation
1
Alexandria real estate equities, inc.
1
Alkermes plc
5
Alnylam pharmaceuticals, inc.
12
Altimmune, inc.
1
Alx oncology holdings inc.
2
Amgen inc.
4
Arrival
1
Astellas pharma inc
2
Astrazeneca plc
10
Avenue therapeutics, inc.
2
Aveo pharmaceuticals, inc.
3
Baxter international inc.
2
Beam therapeutics inc.
1
Beigene, ltd.
1
Biogen inc.
3
Bristol-myers squibb company
6
Eli lilly and company
410
Fortress biotech, inc.
2
Gilead sciences, inc.
2
Glaxosmithkline plc
15
Hutchison china meditech limited
4
Icon plc
2
Incyte corporation
73
Johnson & johnson
27
Kering
2
Ligand pharmaceuticals incorporated
2
Merus n.v.
11
Morgan stanley
2
Nektar therapeutics
4
Novartis ag
11
Novo nordisk a/s
19
Pfizer, inc.
5
Proqr therapeutics n.v.
2
Quanterix corporation
2
Regeneron pharmaceuticals, inc.
2
Rigel pharmaceuticals, inc.
6
Royalty pharma plc
2
Sana biotechnology inc
2
Sanofi
54
Takeda pharmaceutical company limited
3
Teva pharmaceutical industries ltd
6
Thermo fisher scientific inc
2
Vanda pharmaceuticals inc.
2
Veru inc.
23
Viatris inc.
2
Vir biotechnology, inc.
6
Symbols
AAPL
192
ABB
219
ABBV
235
ABLZF
206
ABT
286
AMGN
116
ARVL
714
AZN
119
BDX
122
BMO
183
BMY
186
BNPQF
150
BNPQY
150
CM
116
CSCO
201
CSSE
134
DSX
130
DUK
116
ERIC
276
FE
109
FNCTF
1242
GE
151
GILD
110
GOOG
139
GOOGL
141
GSK
144
HON
253
HUBS
220
INCY
154
INTC
183
IT
377
JNJ
808
LLY
410
LTUM
142
MDT
246
MMM
156
MRK
142
MS
464
MSFT
189
NVDA
130
NVS
198
NVSEF
166
ORCL
203
PCRFF
112
PCRFY
112
PFE
200
PHG
118
PPRUF
169
PPRUY
169
REGN
144
RY
136
SAP
255
SAPGF
227
SNOW
117
SNY
900
SNYNF
740
TAK
118
TEVJF
151
TMO
267
VZ
203
Exchanges
Nasdaq
222
Nyse
410
Crawled Date
2023 - 12 - 15
3
2023 - 10 - 26
3
2023 - 08 - 01
3
2023 - 04 - 18
4
2023 - 01 - 18
3
2022 - 12 - 19
3
2022 - 09 - 19
2
2022 - 09 - 07
2
2022 - 08 - 11
2
2022 - 08 - 04
2
2022 - 07 - 20
2
2022 - 06 - 14
2
2022 - 06 - 07
2
2022 - 06 - 06
4
2022 - 05 - 11
4
2022 - 05 - 04
2
2022 - 04 - 25
3
2022 - 04 - 12
2
2022 - 04 - 11
5
2022 - 03 - 08
3
2022 - 03 - 01
3
2022 - 02 - 24
2
2022 - 02 - 22
2
2022 - 02 - 11
2
2022 - 01 - 24
2
2021 - 12 - 13
2
2021 - 12 - 03
3
2021 - 11 - 11
2
2021 - 11 - 04
3
2021 - 11 - 02
3
2021 - 10 - 18
2
2021 - 10 - 13
3
2021 - 09 - 30
2
2021 - 09 - 28
4
2021 - 09 - 21
3
2021 - 09 - 18
2
2021 - 09 - 16
2
2021 - 08 - 16
3
2021 - 08 - 05
2
2021 - 07 - 09
2
2021 - 06 - 29
2
2021 - 06 - 28
2
2021 - 06 - 24
2
2021 - 06 - 22
4
2021 - 06 - 21
2
2021 - 06 - 18
3
2021 - 06 - 11
2
2021 - 06 - 01
3
2021 - 05 - 27
2
2021 - 05 - 21
2
2021 - 05 - 06
2
2021 - 04 - 16
2
2021 - 04 - 13
2
2021 - 04 - 08
2
2021 - 04 - 07
3
2021 - 04 - 06
2
2021 - 03 - 10
3
2021 - 02 - 10
3
2021 - 01 - 28
2
2021 - 01 - 21
2
Crawled Time
00:00
25
00:20
6
01:00
36
01:15
1
02:00
6
03:00
4
04:20
1
05:00
5
06:00
3
07:00
2
08:00
1
09:00
9
10:00
8
11:00
24
12:00
38
12:07
1
12:11
1
12:15
8
12:20
6
12:30
4
12:39
1
13:00
24
13:01
1
13:15
1
13:20
3
13:30
1
14:00
26
14:20
4
14:30
4
15:00
22
15:20
5
15:30
3
16:00
14
16:20
2
17:00
19
17:07
1
17:12
1
18:00
16
18:17
1
19:00
13
20:00
8
20:20
1
21:00
16
22:00
12
22:04
2
23:00
18
23:07
1
23:12
1
Source
investor.alkermes.com
1
investor.aveooncology.com
1
www.biospace.com
168
www.clarivate.com
1
www.concertpharma.com
1
www.fda.gov
3
www.globenewswire.com
56
www.hutch-med.com
1
www.prnewswire.com
177
www.thermogenesis.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
for
symbols :
Lly
save search
Lilly Confirms Date and Conference Call for First-Quarter 2024 Financial Results Announcement
Published:
2024-04-16
(Crawled : 15:00)
- biospace.com/
LLY
|
News
|
$750.77
0.54%
0.22%
2.8M
|
Health Technology
|
0.0%
|
O:
0.09%
H:
0.0%
C:
0.0%
announcement
conference
for
financial
results
Roche granted FDA Breakthrough Device Designation for blood test to support earlier Alzheimer's disease diagnosis
Published:
2024-04-11
(Crawled : 05:00)
- globenewswire.com
LLY
|
News
|
$750.77
0.54%
0.22%
2.8M
|
Health Technology
|
-0.14%
|
O:
1.06%
H:
0.47%
C:
-0.03%
fda
device
disease
test
granted
blood
designation
for
alzheimer's
roche
Innovent and HUTCHMED Jointly Announce NDA Acceptance in China for Sintilimab Combination with Fruquintinib for the Treatment of Advanced Endometrial Cancer with Priority Review Status
Published:
2024-04-02
(Crawled : 05:00)
- prnewswire.com
LLY
|
News
|
$750.77
0.54%
0.22%
2.8M
|
Health Technology
|
-3.34%
|
O:
-2.79%
H:
1.32%
C:
1.18%
SNY
|
News
|
$46.11
0.68%
0.7%
3.5M
|
Health Technology
|
-5.44%
|
O:
-1.14%
H:
0.02%
C:
-1.06%
review
cancer
treatment
advanced
china
HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Endometrial Cancer with Priority Review Status
Published:
2024-04-02
(Crawled : 05:00)
- globenewswire.com
LLY
|
News
|
$750.77
0.54%
0.22%
2.8M
|
Health Technology
|
-3.34%
|
O:
-2.79%
H:
1.32%
C:
1.18%
SNY
|
News
|
$46.11
0.68%
0.7%
3.5M
|
Health Technology
|
-5.44%
|
O:
-1.14%
H:
0.02%
C:
-1.06%
HCM
|
$16.45
-1.38%
-1.4%
300K
|
Health Technology
|
-1.47%
|
O:
0.21%
H:
1.49%
C:
-0.06%
treatment
advanced
china
Innovent Dosed First Participant in Phase 3 Clinical Study (Neoshot) of IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with Sintilimab for MSI-H/dMMR Colon Cancer Neoadjuvant Therapy
Published:
2024-03-27
(Crawled : 00:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
0.63%
-2.18%
1.4K
|
Health Technology
|
-7.26%
|
O:
-0.26%
H:
0.0%
C:
0.0%
LLY
|
News
|
$750.77
0.54%
0.22%
2.8M
|
Health Technology
|
-3.11%
|
O:
0.49%
H:
0.84%
C:
-0.07%
SNY
|
News
|
$46.11
0.68%
0.7%
3.5M
|
Health Technology
|
-6.28%
|
O:
1.06%
H:
0.0%
C:
0.0%
INCY
|
$52.72
-0.94%
-0.91%
2.1M
|
Health Technology
|
-6.77%
|
O:
-0.09%
H:
1.42%
C:
1.1%
ibi310
first
cancer
colon
therapy
study
Academy Award® Winner Matthew McConaughey Narrates MacGillivray Freeman's 3D Documentary for IMAX® and Giant Screen Theaters "Superhuman Body: World of Medical Marvels"
Published:
2024-03-26
(Crawled : 19:00)
- prnewswire.com
LLY
|
News
|
$750.77
0.54%
0.22%
2.8M
|
Health Technology
|
-3.11%
|
O:
0.49%
H:
0.84%
C:
-0.07%
award
world
medical
Veru Announces the Appointment of Louis Aronne MD as Chief Medical Advisor for its Enobosarm Program for High Quality Weight Loss
Published:
2024-03-12
(Crawled : 12:00)
- globenewswire.com
PFE
A
|
$25.42
-1.05%
0.16%
40M
|
Health Technology
|
-10.4%
|
O:
-0.21%
H:
0.11%
C:
-1.06%
LLY
|
News
|
$750.77
0.54%
0.22%
2.8M
|
Health Technology
|
2.23%
|
O:
0.9%
H:
2.03%
C:
1.89%
VERU
|
$1.16
-7.57%
-7.73%
2.5M
|
Health Technology
|
76.29%
|
O:
-0.53%
H:
2.22%
C:
-3.59%
ALT
|
$7.04
-6.38%
-6.67%
3.2M
|
Commercial Services
|
-23.81%
|
O:
0.3%
H:
11.41%
C:
9.8%
medical
program
Global Angina Pectoris Drugs Market Set for Growth Amid Advancements in Healthcare Infrastructure
Published:
2024-03-11
(Crawled : 23:00)
- prnewswire.com
AZNCF
|
$140.15
3.58%
-4.19%
560
|
Health Technology
|
1.45%
|
O:
2.01%
H:
0.0%
C:
-2.01%
JNJ
|
News
|
$144.77
0.22%
0.22%
7.9M
|
Health Technology
|
-9.3%
|
O:
1.12%
H:
0.0%
C:
0.0%
GSK
|
$39.6
-0.88%
0.03%
2.6M
|
Health Technology
|
-7.74%
|
O:
0.02%
H:
0.79%
C:
0.79%
LLY
|
News
|
$750.77
0.54%
0.22%
2.8M
|
Health Technology
|
2.23%
|
O:
0.9%
H:
2.03%
C:
1.89%
ABBV
|
$164.25
1.05%
0.26%
3M
|
Health Technology
|
-8.7%
|
O:
1.04%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.11
0.68%
0.7%
3.5M
|
Health Technology
|
-4.6%
|
O:
0.01%
H:
0.0%
C:
0.0%
AZN
|
$68.53
0.39%
0.39%
3.2M
|
Health Technology
|
0.88%
|
O:
-0.19%
H:
0.22%
C:
-0.21%
global
set
growth
market
FDA Delays Approval of Donanemab for the Treatment of Early-Stage Alzheimer’sAgency to convene an advisory committee to consider the drug
Published:
2024-03-08
(Crawled : 15:30)
- biospace.com/
LLY
|
News
|
$750.77
0.54%
0.22%
2.8M
|
Health Technology
|
-3.77%
|
O:
-0.02%
H:
0.0%
C:
-2.29%
fda
drug
approval
treatment
Lilly Announces Details of Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting
Published:
2024-03-05
(Crawled : 22:00)
- prnewswire.com
LLY
|
News
|
$750.77
0.54%
0.22%
2.8M
|
Health Technology
|
-3.45%
|
O:
0.86%
H:
0.45%
C:
-0.58%
association
cancer
research
meeting
Merus Announces Financial Results for the Fourth Quarter and Full Year 2023 and Provides Business Update
Published:
2024-02-28
(Crawled : 21:00)
- globenewswire.com
LLY
|
News
|
$750.77
0.54%
0.22%
2.8M
|
Health Technology
|
-0.91%
|
O:
-0.6%
H:
0.45%
C:
0.08%
MRUS
|
$41.05
1.84%
1.71%
410K
|
Health Technology
|
-15.71%
|
O:
2.3%
H:
0.58%
C:
-2.69%
INCY
|
$52.72
-0.94%
-0.91%
2.1M
|
Health Technology
|
-12.1%
|
O:
0.38%
H:
0.0%
C:
-3.07%
business
year
update
financial
results
We Don’t Know What We Don’t Know: LGBTQIA+ Patient Data and the Struggle for ...
Published:
2024-02-22
(Crawled : 12:00)
- biospace.com/
JNJ
|
News
|
$144.77
0.22%
0.22%
7.9M
|
Health Technology
|
-8.4%
|
O:
0.59%
H:
1.11%
C:
0.92%
LLY
|
News
|
$750.77
0.54%
0.22%
2.8M
|
Health Technology
|
0.65%
|
O:
2.37%
H:
1.51%
C:
0.79%
We Don’t Know What We Don’t Know: LGBTQIA+ Patient Data and the Struggle for Inclusivity
Published:
2024-02-22
(Crawled : 09:00)
- biospace.com/
JNJ
|
News
|
$144.77
0.22%
0.22%
7.9M
|
Health Technology
|
-8.4%
|
O:
0.59%
H:
1.11%
C:
0.92%
LLY
|
News
|
$750.77
0.54%
0.22%
2.8M
|
Health Technology
|
0.65%
|
O:
2.37%
H:
1.51%
C:
0.79%
Lilly Edges Out J&J to Top 20 BioPharma Market Cap List for 2023
Published:
2024-02-20
(Crawled : 17:00)
- biospace.com/
MS
|
News
0 d
|
$90.08
1.06%
0.52%
8.2M
|
Finance
|
4.38%
|
O:
-0.65%
H:
0.64%
C:
-0.69%
JNJ
|
News
|
$144.77
0.22%
0.22%
7.9M
|
Health Technology
|
-7.56%
|
O:
0.12%
H:
0.0%
C:
0.0%
LLY
|
News
|
$750.77
0.54%
0.22%
2.8M
|
Health Technology
|
-4.0%
|
O:
1.02%
H:
0.43%
C:
-4.35%
biopharma
market
Global Tire Recycling Downstream Product Market Set to Reach $5.5 Billion by 2030: Rubber Powder to Lead Market Growth Amid Rising Demand for Repurposed Materials
Published:
2024-02-10
(Crawled : 04:20)
- prnewswire.com
LLY
|
News
|
$750.77
0.54%
0.22%
2.8M
|
Health Technology
|
Email alert
Add to watchlist
reach
repurposed
global
set
growth
market
Innovent's First New Drug Application of Mazdutide for Chronic Weight Management has been Accepted by the NMPA of China
Published:
2024-02-07
(Crawled : 09:00)
- prnewswire.com
LLY
|
News
|
$750.77
0.54%
0.22%
2.8M
|
Health Technology
|
6.49%
|
O:
0.76%
H:
4.31%
C:
2.11%
SNY
|
News
|
$46.11
0.68%
0.7%
3.5M
|
Health Technology
|
-0.9%
|
O:
1.33%
H:
0.0%
C:
0.0%
INCY
|
$52.72
-0.94%
-0.91%
2.1M
|
Health Technology
|
-11.59%
|
O:
-0.65%
H:
0.57%
C:
-3.21%
first
management
drug
application
china
Proniras Corporation Secures New Series B Financing and Names New Board Members to Support Phase 1 Study of Novel Treatment for Opiate Withdrawal
Published:
2024-02-01
(Crawled : 22:00)
- biospace.com/
LLY
|
News
|
$750.77
0.54%
0.22%
2.8M
|
Health Technology
|
16.29%
|
O:
0.27%
H:
2.04%
C:
2.02%
corporation
series
treatment
study
American Camp Association Receives $45.5 Million Grant from Lilly Endowment Inc. to Strengthen Character Development Programs for Young People at Camp
Published:
2024-02-01
(Crawled : 19:00)
- prnewswire.com
LLY
|
News
|
$750.77
0.54%
0.22%
2.8M
|
Health Technology
|
13.68%
|
O:
0.3%
H:
1.55%
C:
0.8%
association
million
grant
DP Technology Announces Nomination of Development Candidate, a Potential Best-in-Class Kv1.3 Inhibitor for Immunological Diseases Including IBD and AD
Published:
2024-01-30
(Crawled : 09:00)
- prnewswire.com
LLY
|
News
|
$750.77
0.54%
0.22%
2.8M
|
Health Technology
|
16.4%
|
O:
0.11%
H:
0.17%
C:
-0.11%
technology
potential
Positive Phase 1/2 Clinical Trial Data for an Investigational Gene Therapy for Genetic Hearing Loss to be Presented at the Association for Research in Otolaryngology 2024 MidWinter Meeting
Published:
2024-01-23
(Crawled : 17:00)
- prnewswire.com
LLY
|
News
|
$750.77
0.54%
0.22%
2.8M
|
Health Technology
|
19.0%
|
O:
-0.51%
H:
0.37%
C:
0.32%
genetic
association
positive
research
meeting
trial
therapy
← Previous
1
2
3
4
5
6
7
8
9
…
20
21
Next →
Gainers vs Losers
57%
43%
Top 10 Gainers
INVO
|
$1.82
139.47%
56.82%
220M
|
Health Technology
SINT
|
$0.0373
62.88%
37.26%
460M
|
Health Technology
WISA
4
|
$9.25
51.64%
34.27%
64M
|
Electronic Technology
EDBL
|
News
|
$6.66
46.37%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
600K
|
Manufacturing
TCON
|
$2.29
33.92%
26.61%
1.8M
|
Health Technology
TIRX
|
$0.4848
7.49%
24.58%
5.9M
|
SRFM
4
|
$0.3859
-12.3%
23.84%
660K
|
n/a
KZIA
|
$0.3442
18.28%
23.42%
290K
|
Health Technology
VNDA
|
News
|
$5.24
29.38%
22.56%
24M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.